Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Revenue (2020 - 2022)

Historic Revenue for Immuneering (IMRX) over the last 3 years, with Q4 2022 value amounting to $455.0.

  • Immuneering's Revenue fell 9976.0% to $455.0 in Q4 2022 from the same period last year, while for Sep 2023 it was $455.0, marking a year-over-year decrease of 9991.01%. This contributed to the annual value of $316952.0 for FY2022, which is 8476.16% down from last year.
  • Latest data reveals that Immuneering reported Revenue of $455.0 as of Q4 2022, which was down 9976.0% from $38380.0 recorded in Q3 2022.
  • Over the past 5 years, Immuneering's Revenue peaked at $748200.0 during Q1 2021, and registered a low of $455.0 during Q4 2022.
  • Its 3-year average for Revenue is $384127.1, with a median of $480835.0 in 2020.
  • Its Revenue has fluctuated over the past 5 years, first surged by 3726.95% in 2021, then tumbled by 9976.0% in 2022.
  • Immuneering's Revenue (Quarter) stood at $665080.0 in 2020, then crashed by 71.49% to $189591.0 in 2021, then tumbled by 99.76% to $455.0 in 2022.
  • Its last three reported values are $455.0 in Q4 2022, $38380.0 for Q3 2022, and $94419.0 during Q2 2022.